A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)
Clinical trial NCT01669070 · COMPLETED
Trial details
- NCT number
- NCT01669070
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-15
- Primary completion
- 2012-11-16
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.